These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 8813140

  • 1. Excision of 2',2'-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA.
    Gandhi V, Legha J, Chen F, Hertel LW, Plunkett W.
    Cancer Res; 1996 Oct 01; 56(19):4453-9. PubMed ID: 8813140
    [Abstract] [Full Text] [Related]

  • 2. Action of 2',2'-difluorodeoxycytidine on DNA synthesis.
    Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W.
    Cancer Res; 1991 Nov 15; 51(22):6110-7. PubMed ID: 1718594
    [Abstract] [Full Text] [Related]

  • 3. Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase.
    Fowler JD, Brown JA, Johnson KA, Suo Z.
    J Biol Chem; 2008 May 30; 283(22):15339-48. PubMed ID: 18378680
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preclinical characteristics of gemcitabine.
    Plunkett W, Huang P, Gandhi V.
    Anticancer Drugs; 1995 Dec 30; 6 Suppl 6():7-13. PubMed ID: 8718419
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New Mechanism of Gemcitabine and Its Phosphates: DNA Polymerization Disruption via 3'-5' Exonuclease Inhibition.
    Yang S, Luo D, Li N, Li C, Tang S, Huang Z.
    Biochemistry; 2020 Nov 17; 59(45):4344-4352. PubMed ID: 33147009
    [Abstract] [Full Text] [Related]

  • 10. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
    Gandhi V, Mineishi S, Huang P, Yang Y, Chubb S, Chapman AJ, Nowak BJ, Hertel LW, Plunkett W.
    Semin Oncol; 1995 Aug 17; 22(4 Suppl 11):61-7. PubMed ID: 7481847
    [Abstract] [Full Text] [Related]

  • 11. DNA polymerase mutagenic bypass and proofreading of endogenous DNA lesions.
    Eckert KA, Opresko PL.
    Mutat Res; 1999 Mar 08; 424(1-2):221-36. PubMed ID: 10064863
    [Abstract] [Full Text] [Related]

  • 12. Replication of DNA templates containing 5-formyluracil, a major oxidative lesion of thymine in DNA.
    Zhang QM, Sugiyama H, Miyabe I, Matsuda S, Saito I, Yonei S.
    Nucleic Acids Res; 1997 Oct 15; 25(20):3969-73. PubMed ID: 9321644
    [Abstract] [Full Text] [Related]

  • 13. Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
    Plunkett W, Huang P, Xu YZ, Heinemann V, Grunewald R, Gandhi V.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 11):3-10. PubMed ID: 7481842
    [Abstract] [Full Text] [Related]

  • 14. Gemcitabine: preclinical pharmacology and mechanisms of action.
    Plunkett W, Huang P, Searcy CE, Gandhi V.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 10):3-15. PubMed ID: 8893876
    [Abstract] [Full Text] [Related]

  • 15. On-off regulation of 3' exonuclease excision to DNA polymerization by Exo+ polymerase.
    Zhang J, Li K.
    J Biochem Mol Biol; 2003 Nov 30; 36(6):525-8. PubMed ID: 14659068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cells.
    Gandhi V, Mineishi S, Huang P, Chapman AJ, Yang Y, Chen F, Nowak B, Chubb S, Hertel LW, Plunkett W.
    Cancer Res; 1995 Apr 01; 55(7):1517-24. PubMed ID: 7533664
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.